The Association between Temperament, Chronotype, Depressive Symptoms, and Disease Activity among Patients with Inflammatory Bowel Disease—A Cross-Sectional Pilot Study
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design and Sample
2.2. Questionnaires
2.3. Statistical Analysis
2.4. Data Availability Statement
2.5. Ethics Statement
3. Results
3.1. Intergroup Comparisons
3.2. Correlations
3.3. Linear Regression Models
4. Discussion
Limitations
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Torres, J.; Mehandru, S.; Colombel, J.-F.; Peyrin-Biroulet, L. Crohn’s Disease. Lancet 2017, 389, 1741–1755. [Google Scholar] [CrossRef]
- Ungaro, R.; Mehandru, S.; Allen, P.B.; Peyrin-Biroulet, L.; Colombel, J.-F. Ulcerative Colitis. Lancet 2017, 389, 1756–1770. [Google Scholar] [CrossRef]
- Sweeney, L.; Moss-Morris, R.; Czuber-Dochan, W.; Meade, L.; Chumbley, G.; Norton, C. Systematic Review: Psychosocial Factors Associated with Pain in Inflammatory Bowel Disease. Aliment. Pharmacol. Ther. 2018, 47, 715–729. [Google Scholar] [CrossRef] [Green Version]
- Choi, K.; Chun, J.; Han, K.; Park, S.; Soh, H.; Kim, J.; Lee, J.; Lee, H.J.; Im, J.P.; Kim, J.S. Risk of anxiety and depression in patients with inflammatory bowel disease: A nationwide, population-based study: Short title: Anxiety and depression in IBD. J. Clin. Med. 2019, 8, 654. [Google Scholar] [CrossRef] [Green Version]
- Marrie, R.A.; Graff, L.A.; Fisk, J.D.; Patten, S.B.; Bernstein, C.N. The Relationship Between Symptoms of Depression and Anxiety and Disease Activity in IBD Over Time. Inflamm. Bowel Dis. 2021, 27, 1285–1293. [Google Scholar] [CrossRef]
- Sochal, M.; Małecka-Panas, E.; Gabryelska, A.; Talar-Wojnarowska, R.; Szmyd, B.; Krzywdzińska, M.; Białasiewicz, P. Determinants of Sleep Quality in Inflammatory Bowel Diseases. J. Clin. Med. 2020, 9, 2921. [Google Scholar] [CrossRef]
- Strelau, J.; Zawadzki, B. The Formal Characteristics of Behaviour-Temperament Inventory (FCB-TI): Theoretical Assumptions and Scale Construction. Eur. J. Personal. 1993, 7, 313–336. [Google Scholar] [CrossRef]
- la Barbera, D.; Bonanno, B.; Rumeo, M.V.; Alabastro, V.; Frenda, M.; Massihnia, E.; Morgante, M.C.; Sideli, L.; Craxì, A.; Cappello, M.; et al. Alexithymia and Personality Traits of Patients with Inflammatory Bowel Disease. Sci. Rep. 2017, 7, 1–11. [Google Scholar] [CrossRef] [Green Version]
- Jordan, C.; Sin, J.; Fear, N.T.; Chalder, T. A Systematic Review of the Psychological Correlates of Adjustment Outcomes in Adults with Inflammatory Bowel Disease. Clin. Psychol. Rev. 2016, 47, 28–40. [Google Scholar] [CrossRef] [PubMed]
- Vidal, Á.; Gómez-Gil, E.; Sans, M.; Portella, M.J.; Salamero, M.; Piqué, J.M.; Panés, J. Psychometric Properties of the Original Inflammatory Bowel Disease Questionnaire, a Spanish version. Gastroenterol. Y Hepatol. 2007, 30, 212–218. [Google Scholar] [CrossRef] [PubMed]
- Petruo, V.A.; Krauss, E.; Kleist, A.; Hardt, J.; Hake, K.; Peirano, J.; Krause, T.; Ehehalt, R.; von Arnauld de la Perriére, P.; Büning, J.; et al. Perceived Distress, Personality Characteristics, Coping Strategies and Psychosocial Impairments in a National German Multicenter Cohort of Patients with Crohn’s Disease and Ulcerative Colitis. Z. Fur Gastroenterol. 2019, 57, 473–483. [Google Scholar] [CrossRef]
- McCombie, A.M.; Mulder, R.T.; Gearry, R.B. Coping Strategies and Psychological Outcomes of Patients with Inflammatory Bowel Disease in the First 6 Months after Diagnosis. Inflamm. Bowel Dis. 2015, 21, 2272–2280. [Google Scholar] [CrossRef]
- Bielinski, M.; Lesiewska, N.; Bielinska, J.; Liebert, A.; Mieczkowski, A.; Soponska-Brzoszczyk, P.; Brzoszczyk, B.; Klopocka, M.; Borkowska, A. Affective Temperament in Inflammatory Bowel Diseases: Another Brick in the Wall of Differentiation. PLoS ONE 2018, 13, 1–14. [Google Scholar] [CrossRef]
- Liu, W.; Chen, L.; Yang, Y.; Zhang, S. Psychometric Properties of the Formal Characteristics of Behavior-Temperament Inventory in Chinese Samples. Span. J. Psychol. 2015, 18, E73. [Google Scholar] [CrossRef]
- Hintsa, T.; Wesolowska, K.; Elovainio, M.; Strelau, J.; Pulkki-Råback, L.; Keltikangas-Järvinen, L. Associations of Temporal and Energetic Characteristics of Behavior with Depressive Symptoms: A Population-Based Longitudinal Study within Strelau’s Regulative Theory of Temperament. J. Affect. Disord. 2016, 197, 196–204. [Google Scholar] [CrossRef]
- Oniszczenko, W.; Dragan, W.Ł. Association between Temperament in Terms of the Regulative Theory of Temperament and DRD4 and DAT1 Gene Polymorphisms. Compr. Psychiatry 2012, 53, 789–796. [Google Scholar] [CrossRef] [PubMed]
- Dragan, W.Ł.; Jednoróg, K.; Marchewka, A. Sex-Specific Relationship of Childhood Adversity with Gray Matter Volume and Temperament. Front. Behav. Neurosci. 2019, 13, 71. [Google Scholar] [CrossRef]
- Adan, A.; Archer, S.N.; Hidalgo, M.P.; di Milia, L.; Natale, V.; Randler, C. Circadian Typology: A Comprehensive Review. Chronobiol. Int. 2012, 29, 1153–1175. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Oginska, H.; Mojsa-Kaja, J.; Mairesse, O. Chronotype Description: In Search of a Solid Subjective Amplitude Scale. Chronobiol. Int. 2017, 34, 1388–1400. [Google Scholar] [CrossRef]
- Smith, C.S.; Reilly, C.; Midkiff, K. Evaluation of Three Circadian Rhythm Questionnaires with Suggestions for an Improved Measure of Morningness. J. Appl. Psychol. 1989, 74, 728–738. [Google Scholar] [CrossRef]
- Caci, H.; Adan, A.; Bohle, P.; Natale, V.; Pornpitakpan, C.; Tiley, A. Transcultural Properties of the Composite Scale of Morningness: The Relevance of the “Morning Affect” Factor. Chronobiol. Int. 2005, 22, 523–540. [Google Scholar] [CrossRef]
- Au, J.; Reece, J. The Relationship between Chronotype and Depressive Symptoms: A Meta-Analysis. J. Affect. Disord. 2017, 218, 93–104. [Google Scholar] [CrossRef] [PubMed]
- Mokros, Ł.; Nowakowska-Domagała, K.; Koprowicz, J.; Witusik, A.; Pietras, T. The Association between Chronotype and Suicidality among Students of the Medicine and Psychology Faculties–the Mediating Role of General Mental Health Indices. Chronobiol. Int. 2021, 38, 509–517. [Google Scholar] [CrossRef] [PubMed]
- Merikanto, I.; Lahti, T.; Kronholm, E.; Peltonen, M.; Laatikainen, T.; Vartiainen, E.; Salomaa, V.; Partonen, T. Evening Types Are Prone to Depression. Chronobiol. Int. 2013, 30, 719–725. [Google Scholar] [CrossRef] [Green Version]
- Merikanto, I.; Englund, A.; Kronholm, E.; Laatikainen, T.; Peltonen, M.; Vartiainen, E.; Partonen, T. Evening Chronotypes Have the Increased Odds for Bronchial Asthma and Nocturnal Asthma. Chronobiol. Int. 2014, 31, 95–101. [Google Scholar] [CrossRef]
- Knutson, K.L.; Wu, D.; Patel, S.R.; Loredo, J.S.; Redline, S.; Cai, J.; Gallo, L.C.; Mossavar-Rahmani, Y.; Ramos, A.R.; Teng, Y.; et al. Association Between Sleep Timing, Obesity, Diabetes: The Hispanic Community Health Study/Study of Latinos (HCHS/SOL) Cohort Study. Sleep 2017, 40, zsx014. [Google Scholar] [CrossRef] [PubMed]
- Voigt, R.M.; Forsyth, C.B.; Keshavarzian, A. Circadian Rhythms: A Regulator of Gastrointestinal Health and Dysfunction. Expert Rev. Gastroenterol. Hepatol. 2019, 13, 411–424. [Google Scholar] [CrossRef]
- Knutson, K.L.; von Schantz, M. Associations between Chronotype, Morbidity and Mortality in the UK Biobank Cohort. Chronobiol. Int. 2018, 35, 1045–1053. [Google Scholar] [CrossRef] [Green Version]
- Chakradeo, P.S.; Keshavarzian, A.; Singh, S.; Dera, A.E.; Esteban, J.P.G.; Lee, A.A.; Burgess, H.J.; Fogg, L.; Swanson, G.R. Chronotype, Social Jet Lag, Sleep Debt and Food Timing in Inflammatory Bowel Disease. Sleep Med. 2018, 52, 188–195. [Google Scholar] [CrossRef] [PubMed]
- Chrobak, A.A.; Nowakowski, J.; Zwolińska-Wcisło, M.; Cibor, D.; Przybylska-Feluś, M.; Ochyra, K.; Rzeźnik, M.; Dudek, A.; Arciszewska, A.; Siwek, M.; et al. Associations between Chronotype, Sleep Disturbances and Seasonality with Fatigue and Inflammatory Bowel Disease Symptoms. Chronobiol. Int. 2018, 35, 1142–1152. [Google Scholar] [CrossRef]
- Schroeder, K.W.; Tremaine, W.J.; Ilstrup, D.M. Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative Colitis. A Randomized Study. N. Engl. J. Med. 1987, 317, 1625–1629. [Google Scholar] [CrossRef] [PubMed]
- Sandborn, W.J.; Feagan, B.G.; Wolf, D.C.; D’Haens, G.; Vermeire, S.; Hanauer, S.B.; Ghosh, S.; Smith, H.; Cravets, M.; Frohna, P.A.; et al. Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis. N. Engl. J. Med. 2016, 374, 1754–1762. [Google Scholar] [CrossRef] [PubMed]
- Cichoż-Lach, H.; Michalak, A.; Kopertowska-Majchrzak, M.; Eder, P.; Stawczyk-Eder, K.; Waszak, K.; Talar-Wojnarowska, R.; Zatorski, H.; Solarska-Półchłopek, A.; Chmielnicki, J.; et al. Characteristics of Patients with Moderate-to-Severe Ulcerative Colitis Treated with Vedolizumab: Results from a Polish Multicenter, Prospective, Observational Real-Life Study (the POLONEZ Study). Ther. Adv. Gastroenterol. 2021, 14, 17562848211036456. [Google Scholar] [CrossRef]
- Best, W.R.; Becktel, J.M.; Singleton, J.W.; Kern, F.J. Development of a Crohn’s Disease Activity Index. National Cooperative Crohn’s Disease Study. Gastroenterology 1976, 70, 439–444. [Google Scholar] [CrossRef]
- Jørgensen, L.G.M.; Fredholm, L.; Hyltoft Petersen, P.; Hey, H.; Munkholm, P.; Brandslund, I. How Accurate Are Clinical Activity Indices for Scoring of Disease Activity in Inflammatory Bowel Disease (IBD)? Clin. Chem. Lab. Med. 2005, 43, 403–411. [Google Scholar] [CrossRef]
- Eder, P.; Kłopocka, M.; Wiśniewska-Jarosińska, M.; Talar-Wojnarowska, R.; Maj, D.; Detka-Kowalska, I.; Kierkuś, J.; Śliwczyński, A.; Liebert, A.; Bugajski, M.; et al. Possible Undertreatment of Women with Crohn Disease in Poland. A Subgroup Analysis from a Prospective Multicenter Study of Patients on Anti-Tumor Necrosis Factor Therapy. Pol. Arch. Intern. Med. 2017, 127, 674–680. [Google Scholar] [CrossRef] [Green Version]
- Cyniak-Cieciura, M.; Zawadzki, B.; Strelau, J. Formalna Charakterystyka Zachowania-Kwestionariusz Temperamentu: Wersja Zrewidowana; Pracownia Testów Psychologicznych Polskiego Towarzystwa Psychologicznego: Warszawa, Poland, 2016. [Google Scholar]
- Zawadzki, B.; Popiel, A.; Pragłowska, E. Psychometric Properties of the Polish Version of the Aaron T. Beck’s Depression Inventory BDI-II. Psychol. Etol. Genet. 2009, 19, 71–95. [Google Scholar]
- Beck, A.T.; Steer, R.A.; Brown, G.K. BDI-II. Manual, 2nd ed.; Test Laboratory of the Polish Psychological Association: Warsaw, Poland, 2019. [Google Scholar]
- Cohen, J. Statistical Power Analysis for the Behavioral Sciences; Routledge: Oxford, UK, 2013; ISBN 9781134742776. [Google Scholar]
- Vidal, A.; Gomez-Gil, E.; Sans, M.; Portella, M.J.; Salamero, M.; Piqué, J.M.; Panés, J. Health-Related Quality of Life in Inflammatory Bowel Disease Patients: The Role of Psychopathology and Personality. Inflamm. Bowel Dis. 2008, 14, 977–983. [Google Scholar] [CrossRef]
- Jankowski, K.S. The Role of Temperament in the Relationship between Morningness-Eveningness and Mood. Chronobiol. Int. 2014, 31, 114–122. [Google Scholar] [CrossRef]
- Higgins, P.D.R.; Rubin, D.T.; Kaulback, K.; Schoenfield, P.S.; Kane, S.V. Systematic Review: Impact of Non-Adherence to 5-Aminosalicylic Acid Products on the Frequency and Cost of Ulcerative Colitis Flares. Aliment. Pharmacol. Ther. 2009, 29, 247–257. [Google Scholar] [CrossRef] [Green Version]
- Tabibian, A.; Tabibian, J.H.; Beckman, L.J.; Raffals, L.L.; Papadakis, K.A.; Kane, S.V. Predictors of Health-Related Quality of Life and Adherence in Crohn’s Disease and Ulcerative Colitis: Implications for Clinical Management. Dig. Dis. Sci. 2015, 60, 1366–1374. [Google Scholar] [CrossRef]
- Gao, X.; Tang, Y.; Lei, N.; Luo, Y.; Chen, P.; Liang, C.; Duan, S.; Zhang, Y. Symptoms of Anxiety/Depression Is Associated with More Aggressive Inflammatory Bowel Disease. Sci. Rep. 2021, 11, 1440. [Google Scholar] [CrossRef]
- Mardini, H.E.; Kip, K.E.; Wilson, J.W. Crohn’s Disease: A Two-Year Prospective Study of the Association between Psychological Distress and Disease Activity. Dig. Dis. Sci. 2004, 49, 492–497. [Google Scholar] [CrossRef]
- Guloksuz, S.; Wichers, M.; Kenis, G.; Russel, M.G.V.M.; Wauters, A.; Verkerk, R.; Arts, B.; van Os, J. Depressive Symptoms in Crohn’s Disease: Relationship with Immune Activation and Tryptophan Availability. PLoS ONE 2013, 8, e60435. [Google Scholar] [CrossRef] [Green Version]
- Navabi, S.; Gorrepati, V.S.; Yadav, S.; Chintanaboina, J.; Maher, S.; Demuth, P.; Stern, B.; Stuart, A.; Tinsley, A.; Clarke, K.; et al. Influences and Impact of Anxiety and Depression in the Setting of Inflammatory Bowel Disease. Inflamm. Bowel Dis. 2018, 24, 2303–2308. [Google Scholar] [CrossRef] [PubMed]
- Kayacan, A.G.; Tokay, A. Evaluation of the relationship between chronotype and biochemical findings, nutrition and gastrointestinal symptoms in inflammatory bowel patients. Sleep Med. 2021, 81, 358–364. [Google Scholar] [CrossRef]
- Bernabeu, P.; van-der Hofstadt, C.; Rodríguez-Marín, J.; Gutierrez, A.; Alonso, M.R.; Zapater, P.; Jover, R.; Sempere, L. Effectiveness of a Multicomponent Group Psychological Intervention Program in Patients with Inflammatory Bowel Disease: A Randomized Trial. Int. J. Environ. Res. Public Health 2021, 18, 5439. [Google Scholar] [CrossRef]
- Lamb, C.A.; Kennedy, N.A.; Raine, T.; Hendy, P.A.; Smith, P.J.; Limdi, J.K.; Hayee, B.; Lomer, M.C.E.; Parkes, G.C.; Selinger, C.; et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut 2019, 68, s1–s106. [Google Scholar] [CrossRef] [Green Version]
- Dos Santos, C.H.M.; Galindo, A.C.A.; Da Silva, B.A.; Dantas, C.R.; Guilherme, I.A.D.A.; Gomes, J.E.B.N.; Dallacqua, K.M.; De Souza, M.P.; Senna, P.S. Is There Really a Direct Relationship between IBD and Anxiety/Depression, or Could Any Chronic Disease Have These Manifestations? Inflamm. Bowel Dis. 2021, 27, E18–E19. [Google Scholar] [CrossRef]
- Glapa-Nowak, A.; Bukowska-Posadzy, A.; Szczepanik, M.; Kwiecień, J.; Szaflarska-Popławska, A.; Iwańczak, B.; Flak-Wancerz, A.; Dembiński, Ł.; Osiecki, M.; Kierkuś, J.; et al. Subjective Psychophysical Experiences in the Course of Inflammatory Bowel Disease—A Comparative Analysis Based on the Polish Pediatric Crohn’s and Colitis Cohort (POCOCO). Int. J. Environ. Res. Public Health 2021, 18, 784. [Google Scholar] [CrossRef]
- Denson, L.A.; Curran, M.; McGovern, D.P.B.; Koltun, W.A.; Duerr, R.H.; Kim, S.C.; Sartor, R.B.; Sylvester, F.A.; Abraham, C.; de Zoeten, E.F.; et al. Challenges in IBD Research: Precision Medicine. Inflamm. Bowel Dis. 2019, 25, S31–S39. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Conti, C.; Rosa, I.; Zito, L.; Grossi, L.; Efthymakis, K.; Neri, M.; Porcelli, P. Influence of the COVID-19 Outbreak on Disease Activity and Quality of Life in Inflammatory Bowel Disease Patients. Front. Psychiatry 2021, 12, 1–7. [Google Scholar] [CrossRef] [PubMed]
Name | Definition |
---|---|
Sensory Sensitivity | The ability to detect or react to subtle stimuli or subtle changes in stimuli, e.g., tactile, olfactory, gustatory, visual, or auditory. |
Endurance | The ability to react adequately to prolonged and intensive stimuli—reflects the resistance to distractors and fatigue. |
Emotional Reactivity | A propensity to intensive, emotional reactions—linked to emotional sensitivity and liability. |
Activity | A tendency to engage highly stimulating behaviors. |
Briskness | A tendency to fast reactions and maintenance of high speed of activities—reflects high flexibility to the change of situational conditions. |
Perseverance | A propensity to continue or repeat certain behaviors after the end of the responsible stimuli. |
Rhythmicity | A tendency toward a regular pattern of the circadian rhythm, including the sleep–wake cycle and time of eating. |
Ulcerative Colitis | Crohn’s Disease | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Women (n = 19) | Men (n = 18) | Women (n = 25) | Men (n = 22) | ||||||||
M | SD | M | SD | M | SD | M | SD | p (Sex) | p (Disease) | p (Sex * Disease) | |
Age | 42.01 | 15.95 | 43.27 | 15.38 | 33.95 | 11.82 | 37.26 | 9.67 | 0.433 | 0.018 | 0.724 |
ME | 19.32 | 5.43 | 19.72 | 4.64 | 20.20 | 5.92 | 21.09 | 5.26 | 0.586 | 0.345 | 0.839 |
AM | 22.05 | 3.39 | 20.39 | 4.42 | 21.44 | 3.62 | 19.05 | 4.42 | 0.023 | 0.267 | 0.677 |
Sensory Sensitivity | 41.68 | 5.94 | 40.33 | 5.34 | 42.80 | 4.00 | 44.09 | 5.94 | 0.980 | 0.040 | 0.260 |
Endurance | 32.95 | 4.74 | 33.89 | 5.48 | 31.80 | 5.60 | 37.27 † | 8.65 | 0.025 | 0.427 | 0.110 |
Emotional Reactivity | 40.84 | 8.79 | 38.94 | 6.78 | 42.48 | 7.29 | 35.59 † | 5.89 | 0.007 | 0.591 | 0.120 |
Activity | 36.74 | 7.41 | 37.28 | 12.02 | 36.64 | 7.38 | 38.64 | 6.64 | 0.496 | 0.734 | 0.696 |
Briskness | 40.74 | 4.51 | 43.11 | 8.11 | 39.48 | 6.65 | 44.05 | 6.01 | 0.016 | 0.910 | 0.441 |
Perseverance | 42.68 | 4.92 | 41.33 | 5.01 | 43.64 | 5.18 | 39.73 | 5.09 | 0.021 | 0.771 | 0.254 |
Rhythmicity | 23.63 | 4.47 | 24.44 | 7.25 | 24.48 | 4.91 | 22.09 | 4.67 | 0.505 | 0.525 | 0.178 |
BDI | 9.84 | 9.53 | 11.17 | 9.67 | 17.12 | 11.29 | 10.50 | 7.40 | 0.216 | 0.123 | 0.065 |
Me | Q1–Q3 | Me | Q1–Q3 | Me | Q1–Q3 | Me | Q1–Q3 | p | |||
MAYO | 4.00 | 0.00–5.00 | 4.00 | 1.50–8.50 | 0.488 | ||||||
CDAI | 129.00 | 112.00–242.00 | 71.00 | 40.00–145.00 | 0.040 |
Ulcerative Colitis Patients | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
ME | AM | Sens | Endur | Emot | Act | Brisk | Persev | Rhythm | BDI | |
AM | −0.043 | |||||||||
Sens | 0.088 | −0.235 | ||||||||
Endur | 0.338 * | −0.469 ** | −0.300 | |||||||
Emot | −0.394 * | 0.381 * | −0.185 | −0.509 † | ||||||
Act | 0.462 ** | −0.363 * | −0.139 | 0.568 † | −0.265 | |||||
Brisk | 0.321 | −0.644 † | 0.169 | 0.546 † | −0.454 ** | 0.413 * | ||||
Persv | −0.022 | 0.163 | −0.047 | −0.251 | 0.493 ** | 0.060 | −0.189 | |||
Rhythm | −0.148 | 0.336 * | 0.067 | −0.138 | 0.145 | 0.042 | −0.413 ** | −0.218 | ||
BDI | −0.325 * | 0.415 * | −0.069 | −0.445 ** | 0.491 ** | −0.518 † | −0.546 † | 0.201 | −0.028 | |
Mayo | −0.153 | −0.001 | 0.226 | −0.055 | −0.106 | −0.428 * | 0.191 | −0.531 ** | 0.126 | 0.050 |
Crohn’s disease patients | ||||||||||
ME | AM | Sens | Endur | Emot | Act | Brisk | Persev | Rhythm | BDI | |
AM | 0.160 | |||||||||
Sens | 0.078 | −0.294 * | ||||||||
Endur | 0.051 | −0.496 † | 0.189 | |||||||
Emot | −0.257 | 0.224 | −0.294 * | −0.554 † | ||||||
Act | 0.135 | −0.176 | 0.116 | 0.376 ** | −0.142 | |||||
Brisk | −0.088 | −0.293 * | 0.239 | 0.406 ** | −0.464 ** | 0.140 | ||||
Persv | −0.032 | 0.165 | 0.175 | −0.302 * | 0.545 † | −0.003 | −0.359 * | |||
Rhythm | −0.439 ** | −0.127 | −0.344 * | −0.200 | 0.313 * | −0.240 | −0.049 | −0.021 | ||
BDI | −0.047 | 0.330 * | −0.098 | −0.366 * | 0.551 † | −0.343 ** | −0.597 † | 0.528 † | 0.064 | |
CDAI | 0.045 | 0.194 | −0.040 | 0.029 | 0.154 | −0.261 | −0.046 | 0.190 | −0.054 | 0.420 * |
Prediction of the Mayo Score | |||
---|---|---|---|
Parameter | 95%CI | ||
Intercept | 25.443 | 14.458 | 35.389 |
Age | −0.002 | −0.089 | 0.079 |
Activity | −0.154 | −0.258 | 0.003 |
Perseverance | −0.368 * | −0.575 | −0.077 |
Male sex | 0.043 | −1.250 | 1.193 |
R2 | 0.447 * | 0.146 | 0.537 |
Prediction of the CDAI Score | |||
parameter | 95%CI | ||
Intercept | 51.874 | −88.311 | 154.496 |
Age | 0.818 | −2.280 | 4.660 |
BDI | 3.431 * | 0.684 | 8.679 |
Male sex | −23.068 | −61.130 | 19.779 |
R2 | 0.319 * | 0.046 | 0.440 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Mokros, Ł.; Domżał-Magrowska, D.; Pietras, T.; Sipowicz, K.; Talar-Wojnarowska, R. The Association between Temperament, Chronotype, Depressive Symptoms, and Disease Activity among Patients with Inflammatory Bowel Disease—A Cross-Sectional Pilot Study. Life 2021, 11, 1347. https://doi.org/10.3390/life11121347
Mokros Ł, Domżał-Magrowska D, Pietras T, Sipowicz K, Talar-Wojnarowska R. The Association between Temperament, Chronotype, Depressive Symptoms, and Disease Activity among Patients with Inflammatory Bowel Disease—A Cross-Sectional Pilot Study. Life. 2021; 11(12):1347. https://doi.org/10.3390/life11121347
Chicago/Turabian StyleMokros, Łukasz, Danuta Domżał-Magrowska, Tadeusz Pietras, Kasper Sipowicz, and Renata Talar-Wojnarowska. 2021. "The Association between Temperament, Chronotype, Depressive Symptoms, and Disease Activity among Patients with Inflammatory Bowel Disease—A Cross-Sectional Pilot Study" Life 11, no. 12: 1347. https://doi.org/10.3390/life11121347
APA StyleMokros, Ł., Domżał-Magrowska, D., Pietras, T., Sipowicz, K., & Talar-Wojnarowska, R. (2021). The Association between Temperament, Chronotype, Depressive Symptoms, and Disease Activity among Patients with Inflammatory Bowel Disease—A Cross-Sectional Pilot Study. Life, 11(12), 1347. https://doi.org/10.3390/life11121347